Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $114.74
  • Support level
    $94.52
  • Resistance level
    N/A
  • Beta
    0.3
  • RSI (14-day)
    84.2
  • GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • With a 59.1 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
  • GILD is one of this month's top performers with a return of 16.6 percent, beating 90 percent of stocks in the S&P-100.
  • Up 2.9 percent, GILD is one of this week's biggest gainers.
  • Volatility is forecast to fall over the next month.
  • With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.
52-week range
52-week low 52-week high Price as % of range
$63.15 $115.99 98.2%
Moving averages
200 day 50 day 20 day 10 day
$83.83 $98.09 $105.98 $111.77

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    8.6%
  • In the next month
    16.1%
  • In the next year
    49.1%
Volatility estimates (annualized standard deviations)
Period Value
Historical (5 year) 26.2%
Last month 24.3%
Current estimate 31.8%
Next month forecast 28.5%